scholarly journals An apolipoprotein B100 mimotope prevents obesity in mice

2015 ◽  
Vol 130 (2) ◽  
pp. 105-116 ◽  
Author(s):  
Hyo Joon Kim ◽  
Hee Jong Lee ◽  
Jung Soon Choi ◽  
Jemin Han ◽  
Ji Young Kim ◽  
...  

Immunization with an ApoB100 mimotope prevents high-fat-diet-induced obesity in mice. Antibody titres parallel the weight decrements. In vitro data implicate increased lipolysis and reduced lipoprotein uptake by adipocytes, as well as increased uptake and metabolism of native lipoprotein by macrophages.

2015 ◽  
Vol 2015 ◽  
pp. 1-13 ◽  
Author(s):  
Karine Maria Martins Bezerra Carvalho ◽  
José Delano Barreto Marinho Filho ◽  
Tiago Sousa de Melo ◽  
Ana Jérsia Araújo ◽  
Josiane da Silva Quetz ◽  
...  

Herbal compounds rich in triterpenes are well known to regulate glucose and lipid metabolism and to have beneficial effects on metabolic disorders. The present study investigated the antiobesity properties of resin fromProtium heptaphyllum(RPH) and the possible mechanisms in mice fed a high-fat diet (HFD) for 15 weeks. Mice treated with RPH showed decreases in body weight, net energy intake, abdominal fat accumulation, plasma glucose, amylase, lipase, triglycerides, and total cholesterol relative to their respective controls, which were RPH unfed. Additionally, RPH treatment, while significantly elevating the plasma level of ghrelin hormone, decreased the levels of insulin, leptin, and resistin. Besides, HFD-induced increases in plasma levels of proinflammatory mediators TNF-α, IL-6, and MCP-1 were significantly lowered by RPH. Furthermore,in vitrostudies revealed that RPH could significantly inhibit the lipid accumulation in 3T3-L1 adipocytes (measured by Oil-Red O staining) at concentrations up to 50 μg/mL. These findings suggest that the antiobese potential of RPH is largely due to its modulatory effects on various hormonal and enzymatic secretions related to fat and carbohydrate metabolism and to the regulation of obesity-associated inflammation.


2014 ◽  
Vol 9 ◽  
pp. 211-224 ◽  
Author(s):  
Jihang Chen ◽  
Hoi Shan Wong ◽  
Hoi Yan Leung ◽  
Pou Kuan Leong ◽  
Wing Man Chan ◽  
...  

Diabetologia ◽  
2018 ◽  
Vol 61 (9) ◽  
pp. 2030-2042 ◽  
Author(s):  
Steef Kurstjens ◽  
Janna A. van Diepen ◽  
Caro Overmars-Bos ◽  
Wynand Alkema ◽  
René J. M. Bindels ◽  
...  

Author(s):  
Sarmila Nepali ◽  
Do‑Kuk Kim ◽  
Hoon‑Yeon Lee ◽  
Hyeon‑Hui Ki ◽  
Bo‑Ram Kim ◽  
...  

2019 ◽  
Vol 28 (4) ◽  
pp. 1207-1215 ◽  
Author(s):  
Denis Nchang Che ◽  
Hyun Ju Kang ◽  
Byoung Ok Cho ◽  
Jae Young Shin ◽  
Seon Il Jang

Cells ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. 1245 ◽  
Author(s):  
Vanessa D’Antongiovanni ◽  
Laura Benvenuti ◽  
Matteo Fornai ◽  
Carolina Pellegrini ◽  
Renè van den Wijngaard ◽  
...  

The role played by adenosine A2B receptors (A2BRs) in the regulation of enteric glial cell (EGC) functions remains unclear. This study was aimed at investigating the involvement of A2BRs in the control of EGC functions in a model of obesity. C57BL/6 mice were fed with standard diet (SD) or high fat diet (HFD) for eight weeks. Colonic tachykininergic contractions were recorded in the presence of BAY60-6583 (A2BRs agonist), MRS1754 (A2BRs antagonist), and the gliotoxin fluorocitrate. Immunofluorescence distribution of HuC/D, S100β, and A2BRs was assessed in whole mount preparations of colonic myenteric plexus. To mimic HFD, EGCs were incubated in vitro with palmitate (PA) and lipopolysaccharide (LPS), in the absence or in the presence of A2BR ligands. Toll-like receptor 4 (TLR4) expression was assessed by Western blot analysis. Interleukin-1β (IL-1β), substance P (SP), and glial cell derived neurotrophic factor (GDNF) release were determined by enzyme-linked immunosorbent assay (ELISA) assays. MRS1754 enhanced electrically evoked tachykininergic contractions of colonic preparations from HFD mice. BAY60-6583 decreased the evoked tachykininergic contractions, with higher efficacy in HFD mice. Such effects were blunted upon incubation with fluorocitrate. In in vitro experiments on EGCs, PA and LPS increased TLR4 expression as well as IL-1β, GDNF, and SP release. Incubation with BAY60-6583 reduced TLR4 expression as well as IL-1β, GDNF, and SP release. Such effects were blunted by MRS1754. The present results suggest that A2BRs, expressed on EGCs, participate in the modulation of enteric inflammation and altered tachykininergic responses associated with obesity, thus representing a potential therapeutic target.


2018 ◽  
Vol 114 (suppl_1) ◽  
pp. S34-S34
Author(s):  
V Galand ◽  
N Mougenot ◽  
A Coulombe ◽  
N Suffee-Mosbah ◽  
N Doisne ◽  
...  

Diabetes ◽  
2011 ◽  
Vol 60 (10) ◽  
pp. 2465-2473 ◽  
Author(s):  
D. V. Chartoumpekis ◽  
P. G. Ziros ◽  
A. I. Psyrogiannis ◽  
A. G. Papavassiliou ◽  
V. E. Kyriazopoulou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document